Oak Thistle LLC Makes New $2.10 Million Investment in Encompass Health Co. (NYSE:EHC)

Oak Thistle LLC purchased a new position in shares of Encompass Health Co. (NYSE:EHC) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 22,726 shares of the company’s stock, valued at approximately $2,099,000. Encompass Health makes up approximately 0.6% of Oak Thistle LLC’s holdings, making the stock its 23rd biggest holding.

Other institutional investors have also recently made changes to their positions in the company. UMB Bank n.a. grew its holdings in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares in the last quarter. V Square Quantitative Management LLC lifted its position in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares during the period. Avior Wealth Management LLC bought a new position in shares of Encompass Health during the third quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. increased its holdings in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after buying an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in Encompass Health in the second quarter worth approximately $58,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on EHC shares. Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. KeyCorp lifted their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. UBS Group lifted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Finally, Barclays increased their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Encompass Health currently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Stock Up 0.4 %

EHC stock opened at $92.95 on Wednesday. The stock has a market capitalization of $9.36 billion, a PE ratio of 22.45, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. Encompass Health Co. has a 52 week low of $67.94 and a 52 week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a 50 day moving average of $97.91 and a 200 day moving average of $93.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the firm posted $0.86 earnings per share. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. Sell-side analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.